Oncogenic PI3K/AKT signaling drives metabolic reprogramming to sustain tumor growth by promoting glucose and nutrient uptake and activation of glycolytic and lipogenic enzymes through mTORC1 activation (Figure 6) [75]. This evidence concerns the gene AKT1 and neoplasm.